Literature DB >> 3863701

Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice.

D Kessel, T Corbett.   

Abstract

Both impaired drug accumulation and appearance of a new membrane glycoprotein species (mol. wt. approx. 180,000) are often associated with high levels of drug-induced resistance to a group of natural products which includes adriamycin (ADR) and daunorubicin (DNR). In this study, we examined solid murine mammary, pancreatic and colon tumors varying in degrees of inherent or (in vivo) induced adriamycin resistance. Neither impaired drug accumulation nor alterations in membrane glycoprotein patterns were correlated with drug resistance in these tumors. These results suggest that permeability and glycoprotein alterations may only be associated with very high degrees of drug resistance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863701     DOI: 10.1016/0304-3835(85)90074-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Adriamycin binding assay: a valuable chemosensitivity test in human osteosarcoma.

Authors:  N Baldini; K Scotlandi; M Serra; K Kusuzaki; T Shikita; M C Manara; D Maurici; M Campanacci
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo.

Authors:  S Radel; I Bankusli; E Mayhew; Y M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Comparative efficacy of DMP 840 against mouse and human solid tumor models.

Authors:  P LoRusso; L Demchik; M Dan; L Polin; J L Gross; T H Corbett
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

4.  Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice.

Authors:  P Mucci-LoRusso; L Polin; L A Biernat; F A Valeriote; T H Corbett
Journal:  Invest New Drugs       Date:  1990-08       Impact factor: 3.850

5.  Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer.

Authors:  J A Moscow; A J Townsend; M E Goldsmith; J Whang-Peng; P J Vickers; R Poisson; S Legault-Poisson; C E Myers; K H Cowan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Reversal of multidrug resistance by phenothiazines and structurally related compounds.

Authors:  A Ramu; N Ramu
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.

Authors:  Thomas H Corbett; Kathryn White; Lisa Polin; Juiwanna Kushner; Jennifer Paluch; Chuan Shih; Cora Sue Grossman
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

Review 8.  5-Fluorouracil containing combinations in murine tumor systems.

Authors:  T H Corbett; M C Bissery; P Mucci-LoRusso; L Polin
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

9.  Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02.

Authors:  T S Priebe; E N Atkinson; B F Pan; J A Nelson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells.

Authors:  S Radel; W Fredericks; E Mayhew; R Baker
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.